Drugs / standard trivalent inactivated poliovirus vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02111135 Comparator | Apr → Sep 2014 | poliomyelitis | Vaxtrials S.A. | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | standard trivalent inactivated poliovirus vaccine | “standard trivalent inactivated poliovirus vaccine (t-IPV)” NCT02111135 ↗ |
| Known as | t-IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02111135 ↗ |
| Modality | Vaccine | “standard trivalent inactivated poliovirus vaccine (t-IPV)” NCT02111135 ↗ |